Maurice Chagnaud has been named the new chief executive officer of Polpharma, the largest Polish pharmaceutical group. Dr. Chagnaud, who has over twenty years’ experience in top management positions in the European pharmaceutical industry, is expected to further accelerate the development of Polpharma to become a regional leader in CEE, CIS and Central Asia. The Polpharma Group is among the top 20 generic drug manufacturers in the world. It is a leading generics player based in Poland, operatin...